About ATI Pharma
Board of Directors
Our board brings together decades of expertise in life sciences, finance, regulatory affairs, and global healthcare strategy.
Leadership & Governance
Guiding our mission
ATI Pharma's Board of Directors provides strategic oversight and governance, ensuring the company remains focused on its mission to deliver evidence-based healthcare solutions.
Our directors bring diverse backgrounds spanning pharmaceutical development, corporate governance, investment, and regulatory science.
Carmella T. Angus MSc., MBA
CEO and Chairman of the Board for Canada and USA
Ms. Angus is a seasoned healthcare executive and entrepreneur with over three decades of experience spanning pharmaceutical commercialization, medical technology, defense R&D, and academic healthcare innovation.
Ms. Angus has founded and led multiple companies, including AC Nova Technologies and Nova DenTech, driving significant P&L growth, executing successful acquisitions, and delivering strong investor returns.
Ms. Angus' career includes co-leading the global launch of Lipitor at Warner-Lambert/Pfizer and recently directing the operational and strategic launch of a contract research organization at the University of Manitoba's Center for Healthcare Innovation.
Holding an MBA in Global Business Management and an MSc in Neuroscience and Cardiovascular Medicine from the University of Toronto, she brings a rare combination of clinical expertise, entrepreneurial leadership, and enterprise-scale execution.